Syntekabio Inc.

POLARIS(qb) and Syntekabio sign MOU for Collaborative AI and Quantum-powered Drug Development Service

Syntekabio Inc.: Syntekabio and metaclipse sign for joint research on personalized immunotherapy for cancer

Revolutionize Preclinical Drug Candidate Discovery with Syntekabio

Syntekabio at The BIO International Convention, June 5-8

Syntekabio Inc.: 2023 Trends in New Drug Development

New Cloud Platform “STB CLOUD” Disrupts AI Drug Discovery Worldwide

New cloud platform ‘STB CLOUD’ disrupts AI Drug discovery worldwide

A.I. in New Drug Discovery and Development Takes Center Stage at New York Health Forum (226330.KQ)

Syntekabio and MDBioLab Collaborate on Groundbreaking Anticancer Research